The field of nanotechnology has excellent potential for developing innovative methods to diagnose cancer and provide improved methods for therapy. To fully exploit this new technology future researchers must receive multi-disciplinary training in cancer research and physical sciences/engineering. The mission of the Center for Cross Training Translational Cancer Researchers in Nanotechnology (CRIN) program is to provide cross-training to predoctoral students, postdoctoral scientists, and physicians in nanoscience, nanotechnology, and other emerging technologies, cancer biology, and translational research. Young scientists will be trained in nanoscience, nanoengineering, mesoscale engineering, and image recognition to cancer research. CRIN will build on existing cancer research programs, through the NCI designated UCSD Comprehensive Cancer Center, and nanotechnology focused research programs, including UCSD's Center of Cancer Nanotechnology Excellence and In vivo Cellular and Molecular Imaging Center. The faculty participants are successful researchers with over $27 million in research funding, and are experienced mentors. The program will support 5 graduate students and 2 post-doctoral fellows for two years each, and will provide new opportunities for training underrepresented minorities in cancer nanotechnology research. The program will include research based cross-training, didactic training, workshops, seminars, journal clubs, and professional development activities. CRIN will also develop outreach activities for clinicians, research scientists, and the community.
Nanotechnology approaches hold great promise to produce novel diagnostics, imaging agents, and therapies for cancer. The proposed program will train multi-disciplinary researchers who will use advanced technologies to develop improved methods to diagnose and treat cancer patients.
|Ta, Casey N; Kono, Yuko; Eghtedari, Mohammad et al. (2018) Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings. Radiology 286:1062-1071|
|Schutt, Carolyn; Ibsen, Stuart; Zahavy, Eran et al. (2017) Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin. Pharm Res 34:2025-2035|
|de Gracia Lux, C; Vezeridis, A M; Lux, J et al. (2017) Novel method for the formation of monodisperse superheated perfluorocarbon nanodroplets as activatable ultrasound contrast agents. RSC Adv 7:48561-48568|
|Mendez, Natalie; Liberman, Alexander; Corbeil, Jacqueline et al. (2017) Assessment of in vivo systemic toxicity and biodistribution of iron-doped silica nanoshells. Nanomedicine 13:933-942|
|Huang, Yuran; Vezeridis, Alexander M; Wang, James et al. (2017) Polymer-Stabilized Perfluorobutane Nanodroplets for Ultrasound Imaging Agents. J Am Chem Soc 139:15-18|
|Luk, Brian T; Fang, Ronnie H; Hu, Che-Ming J et al. (2016) Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors. Theranostics 6:1004-11|
|Wang, Fei; Fang, Ronnie H; Luk, Brian T et al. (2016) Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant Staphylococcus aureus Skin Infection. Adv Funct Mater 26:1628-1635|
|Ruff, Laura E; Sapre, Ajay A; Plaut, Justin S et al. (2016) Selection of DNA nanoparticles with preferential binding to aggregated protein target. Nucleic Acids Res 44:e96|
|Schutt, Carolyn E; Ibsen, Stuart; Benchimol, Michael et al. (2015) Optical detection of harmonic oscillations in fluorescent dye-loaded microbubbles ensonified by ultrasound. Opt Lett 40:2834-7|
|Sandoval, Sergio; Mendez, Natalie; Alfaro, Jesus G et al. (2015) Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform. J Biomed Opt 20:88003|
Showing the most recent 10 out of 41 publications